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Summary
The modification of behavior in response to experience is crucial for animals to adapt to 
environmental changes. Although factors such as neuropeptides and hormones are known to 
function in the switch between alternative behavioral states, the mechanisms by which these 
factors transduce, store, retrieve and integrate environmental signals to regulate behavior are 
poorly understood. The rate of locomotion of the nematode Caenorhabditis elegans depends on 
both current and past food availability. Specifically, C. elegans slows its locomotion when it 
encounters food, and animals in a food-deprived state slow even more than animals in a well-fed 
state. The slowing responses of well-fed and food-deprived animals in the presence of food 
represent distinct behavioral states, as they are controlled by different sets of genes, 
neurotransmitters and neurons. Here we describe an evolutionarily conserved C. elegans protein, 
VPS-50, that is required for animals to assume the well-fed behavioral state. Both VPS-50 and its 
murine homolog mVPS50 are expressed in neurons, are associated with synaptic and dense-core 
vesicles and control vesicle acidification and hence synaptic function, likely through regulation of 
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the assembly of the V-ATPase complex. We propose that dense-core vesicle acidification 
controlled by the evolutionarily conserved protein VPS-50/mVPS50 affects behavioral state by 
modulating neuropeptide levels and presynaptic neuronal function in both C. elegans and 
mammals.
Introduction
Like other animals, C. elegans modulates its behavior in response to both environmental 
signals and past experience [1, 2]. For example, both well-fed and food-deprived worms 
slow their locomotion after encountering food, and well-fed worms slow less than food-
deprived worms (Fig. 1A), presumably because food-deprived animals have a greater need to 
be in the proximity of food. The responses of well-fed and food-deprived worms upon 
encountering food require different sets of genes, neurotransmitters and neurons, indicating 
that these responses reflect two distinct behavioral states [1, 2]. The mechanisms by which 
animals integrate information about their current environment and their past experience to 
modulate behavior are poorly understood.
Mutations that impair the maturation of dense-core vesicles and neuropeptide signaling alter 
the locomotion behavior of C. elegans [3]. Whereas synaptic vesicles transport and release 
neurotransmitters, such as acetylcholine, GABA and glutamate, dense-core vesicles 
transport and release neuromulators, such as biogenic amines and neuropeptides. In 
mammals, specific neuropeptides have been associated with the assumption of one of two 
alternative behavioral states, including hunger-satiety and sleep-wakefulness [4, 5].
From genetic screens, we isolated mutants of C. elegans that behave similarly whether they 
have been well-fed or food-deprived. We have characterized one gene defined by these 
mutations, vps-50, and show that while vps-50 mutants behave as if they have been food-
deprived, they are not malnourished but rather failing to switch behavioral states: they 
behave as if food-deprived even when well-fed. We describe below the characterization of 
both C. elegans VPS-50 and its murine homolog, mVPS50 and show that both function in 
dense-core vesicle maturation and acidification.
Results
vps-50 regulates C. elegans behavior
To understand the mechanisms that control the behavioral states of C. elegans in response to 
food availability and past feeding experience, we have characterized three allelic mutations, 
ox476, n3925 and n4022, that cause well-fed animals to behave as if they had been food-
deprived (Fig. 1A). ox476, n3925 and n4022 are alleles of an evolutionarily conserved gene, 
C44B9.1, which we have named vps-50 (see below) (Fig. S1A–C). vps-50 mutants have 
normal rates of pharyngeal pumping and do not display the slow growth and abnormal 
pigmentation of starved wild-type animals (Fig. 1B–C), indicating that vps-50 mutants are 
not malnourished but rather are in the behavioral state normally induced by acute food 
deprivation. vps-50 mutants are abnormal not only in locomotion but also in egg laying, as 
they retain eggs for an abnormally long period of time and lay eggs at substantially later 
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developmental stages than do wild-type worms (Fig. 1D). Food-deprived wild-type worms 
are similarly abnormal in egg laying, further indicating that vps-50 mutants are in a food-
deprived state when not food-deprived.
vps-50 acts in neurons to control C. elegans behavior
We examined the expression pattern of a transgene that expresses a VPS-50::GFP fusion 
under the control of the vps-50 promoter and observed that vps-50 is expressed broadly in 
the nervous system and possibly in all neurons (Fig. 2 and data not shown). These 
observations suggest that vps-50 plays a specific role in neuronal function. To determine 
where vps-50 functions, we used transgenes that express vps-50 in a tissue-specific manner 
and attempted to rescue the mutant phenotype of vps-50 mutants. Expression of vps-50 
using the rab-3 pan-neuronal promoter significantly rescued both the locomotion and egg-
laying defects of vps-50(n4022) mutants, while expression in body-wall muscles using the 
myo-3 promoter failed to rescue the locomotion and egg-laying defects of vps-50 mutants 
(Fig. 1D & 2B). We conclude that vps-50 functions in neurons.
To analyze further the cellular sites of function of VPS-50 in the nervous system, we 
expressed vps-50 in subsets of neurons. VPS-50 expression in cholinergic neurons in vps-50 
mutants using the unc-17 promoter rescued the locomotion defect of well-fed vps-50 mutant 
worms in the presence of food, while vps-50 expression in GABAergic neurons using the 
unc-47 promoter did not improve the locomotion of well-fed vps-50 mutants in the presence 
of food (Fig. 2C). These observations suggest that vps-50 functions in cholinergic neurons to 
control locomotion. Expression of vps-50 using the tax-2 promoter, which drives expression 
in the main sensory neurons that control olfaction, gustation and thermotaxis, did not rescue 
the locomotion defect of vps-50 mutant worms, suggesting that this behavioral defect of 
vps-50 mutants is not a consequence of altered food sensing (Fig. 2C).
VPS-50 is highly conserved from worms to mammals (Fig. S1B), and pan-neuronal 
expression in vps-50 mutant worms of its murine homolog mCCDC132, which we refer to 
as mVPS50, rescued the locomotion defect of vps-50 mutants (Fig. 2B). Thus, C. elegans 
VPS-50 and murine mVPS50 not only are similar in sequence but also are functionally 
similar and likely act in similar molecular processes.
VPS-50 and its murine homolog associate with synaptic vesicles
Using an anti-GFP antibody to visualize a VPS-50::GFP fusion protein in C. elegans whole 
mounts, we observed VPS-50::GFP in neuronal cell bodies and also at synapse-rich regions 
such as the nerve ring (Fig. 2D). In C. elegans, both synaptic and dense-core vesicles as well 
as their associated proteins are transported to synapses by the kinesin-like protein UNC-104/
KIF1A [6, 7]. Like the transport of the vesicular SNARE protein synaptobrevin (SNB-1), the 
transport of VPS-50 to the nerve ring required UNC-104/KIF1A, suggesting that VPS-50 
associates with synaptic or dense-core vesicles (Fig. 2D).
The mammalian Vps50 gene (also known as CCDC132 or Syndetin) has been reported to be 
highly expressed in many regions of both the mouse and the human brains [8]. Using an 
antibody against VPS50, we determined that the mVPS50 protein is widely expressed in the 
mouse brain throughout development (Fig. 3A–C) and in most and possibly all excitatory 
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and inhibitory neurons (Fig. 3D). We examined the distribution of mVPS50 in mouse 
cultured primary cortical and hippocampal neurons. mVPS50 did not colocalize with the cis-
Golgi apparatus marker GM130 (Fig. 4A) but did substantially colocalize with the trans-
Golgi markers Golgin-97 and TGN38 (Fig. 4B & S3A). These observations suggest that 
mVPS50 is at least partially localized to the trans-Golgi. The trans-Golgi apparatus has been 
proposed to be the final sorting compartment for both synaptic and dense-core vesicles [10]. 
Based on this information and our observation that C. elegans VPS-50 associates with 
synaptic or dense-core vesicles, we analyzed the colocalization of mVPS50 with dense-core 
vesicles in mouse cultured primary neurons. mVPS50 colocalized with dense-core vesicles 
that contained Chromogranin C or neuropeptide Y (Fig. 4C–D). The mVPS50 signal did not 
extend as far in the neuronal processes as did the neuropeptide signals, so it is possible that 
the colocalization observed between mVPS50 and neuropeptides is limited to the trans-
Golgi apparatus and to early vesicles budding from it.
We fractionated extracts of adult mouse cortex and showed that mVPS50 was enriched in a 
fraction that contained synaptic and dense-core vesicles (LP2), suggesting that like C. 
elegans VPS-50 the murine protein is associated with synaptic or dense-core vesicles (Fig. 
4E). The LP2 fraction, which is the pellet obtained after centrifugation of fraction LS1, also 
contained neuropeptides, as indicated by the detection of Chromogranin C. We further 
fractionated the synaptic vesicle and cytosol LS1 fraction using a sucrose density gradient. 
The distribution of mVPS50 is like that of the clathrin heavy chain, which assembles onto 
vesicle membranes, and not like that of the membrane-bound synaptophysin or that of the 
neuropeptide Chromogranin C (Fig. 4F). We concluded that mVPS50 likely associates with 
synaptic vesicles as a soluble protein and is not in the lumen of vesicles or integrated into 
synaptic and dense-core vesicle membranes. We have not observed VPS-50 or mVPS50 at 
synapses in C. elegans or in mouse cultured primary neurons, respectively, indicating that 
these proteins likely associate with immature synaptic and dense-core vesicles budding from 
the trans-Golgi but do not traffic all the way to mature synapses (data not shown).
vps-50 mutant animals have a defect in dense-core vesicle maturation
The behavioral defects of vps-50 mutant worms are strikingly similar to those of mutants in 
unc-31 (the worm homolog of mammalian CADPS2/CAPS), rab-2 (the homolog of RAB2, 
which is also known as unc-67 and unc-108 in C. elegans) and rund-1 (the ortholog of 
RUNDC1), genes involved in the release and maturation of dense-core vesicles, but not like 
those of animals mutant for egl-3, which encodes a proprotein convertase that cleaves 
neuropeptides (Fig. 5A & Fig. S4) [3, 11–14]. unc-31 affects the release of dense-core but 
not of synaptic vesicles [12], suggesting that VPS-50 functionally affects dense-core 
vesicles. Dense-core vesicles release biogenic amines and neuropeptides. cat-2 and tph-1 
mutants, which are deficient in the synthesis of dopamine and serotonin, respectively, and 
cat-2 tph-1 tdc-1 triple mutant animals, which are defective for the synthesis of all known 
biogenic amines in C. elegans [15–17], did not display the vps-50 mutant phenotype (Fig. 
5B), suggesting that VPS-50 functions in neuropeptide signaling.
To determine if vps-50 affects neuropeptides, we used a FLP-3::Venus neuropeptide fusion 
protein to analyze neuropeptide levels, localization, release and processing [13]. unc-31 
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(CADPS2/CAPS) mutants, which are impaired in the release of dense-core vesicles [12], 
and egl-3 (PC2) mutants, which are impaired in the processing of neuropeptides [18], 
accumulated elevated levels of FLP-3::Venus at synapses in the dorsal nerve cord. By 
contrast, rab-2 mutants, which are defective in dense-core vesicle maturation, have been 
reported to have decreased levels of neuropeptides at synapses [13]. vps-50 mutants, like 
rab-2 mutants, had decreased levels of FLP-3::Venus at synapses, revealing that vps-50 
function is necessary for normal levels of synaptic neuropeptides (Fig. 5C). The 
FLP-3::Venus fusion did not significantly accumulate in cell bodies of vps-50 mutants, 
indicating that their low levels of neuropeptides at synapses were not the result of a transport 
defect (Fig. 5D).
Synaptic levels of neuropeptides could be low in vps-50 mutants either because of defects in 
producing neuropeptides or because these mutants degrade or release neuropeptides faster 
than wild-type animals. To assess the rate of neuropeptide release, we quantified 
FLP-3::Venus levels in coelomocytes, scavenger cells that take up secreted proteins from the 
worm’s body cavity [19]. Neuropeptide levels in coelomocytes correlate with the 
neuropeptide levels released from neurons [12, 20]. Coelomocytes in vps-50 mutants 
exhibited abnormally low levels of FLP-3::Venus (Fig. 5E), indicating that vps-50 mutants 
are not secreting neuropeptides faster than do wild-type animals. Taken together, these 
results suggest that vps-50 mutants, like rab-2 mutants, produce low levels of neuropeptides. 
The effect of vps-50 on neuropeptide levels at synapses is not limited to FLP-3, as an 
NLP-21::Venus reporter also showed low levels at synapses in vps-50 mutants as compared 
to wild-type animals (Fig. 5I). We postulate that mutation of vps-50 has a broad impact on 
neuropeptides and that the behavioral defects of vps-50 mutants is the result of the 
perturbation of one or of multiple neuropeptides.
We further compared vps-50 and rab-2 mutants using a transgene that expresses the dense-
core vesicle marker IDA-1::GFP [13]. As previously reported, rab-2 mutants have increased 
levels of IDA-1::GFP in cell bodies and lower levels of IDA-1::GFP at synapses, reflecting 
their defect in dense-core vesicle maturation. By contrast, vps-50 mutants had elevated 
levels of IDA-1::GFP in both cell bodies and at synapses (Fig. 5F–G), indicating that vps-50 
and rab-2 both affect dense-core vesicle maturation and do so with some differences.
Neuropeptides are produced from proproteins, which in C. elegans are cleaved into peptides 
by the proprotein convertase 2 enzyme EGL-3 [18]. We asked if vps-50 mutants are 
defective in neuropeptide processing. We examined FLP-3::Venus from protein extracts 
using immunoblotting and observed that vps-50 mutants had reduced levels of FLP-3 and 
that the ratio of processed to unprocessed FLP-3 was significantly lower than in the wild 
type (Fig. 5H).
In short, our results suggest that the behavioral defects of vps-50, unc-31 and rab-2 mutants 
are similar because all three are low in neuropeptide release. However, vps-50 mutants are 
distinct, because unlike unc-31 mutants they did not accumulate neuropeptides at synapses 
and unlike rab-2 mutants they had elevated levels of the dense-core vesicle protein 
IDA-1::GFP at synapses.
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VPS-50 and its murine homolog affect synaptic and dense-core vesicle acidification
To identify physical partners of VPS-50, we purified recombinant VPS-50 sections fused to 
glutathione-S-transferase (GST-VPS-50) and probed a protein extract from wild-type C. 
elegans in a pull-down experiment. Using mass spectrometry, we identified VHA-15, a 
homolog of the H subunit of the V-ATPase complex [21], as a possible VPS-50 interactor 
(data not shown). We confirmed the interaction between VPS-50 and VHA-15, which might 
be direct or indirect, using the yeast two-hybrid system (Fig. 6A). The V-ATPase complex is 
a proton pump that acidifies cellular compartments, including synaptic and dense-core 
vesicles, the lysosome and the trans-Golgi apparatus [21, 22]. In neurons, V-ATPase activity 
is required for loading neurotransmitters into synaptic vesicles [23], and its disruption can 
impair neuropeptide processing because of a failure in acidifying vesicles to the pH 
optimum of processing enzymes [24]. Given the interaction between VPS-50 and VHA-15, 
we postulated that VPS-50 regulates or responds to the activity of the V-ATPase complex 
responsible for the acidification of synaptic and dense-core vesicles.
To investigate the effect of impaired V-ATPase function in neurons, we examined mutants 
defective in the V-ATPase subunit UNC-32, which is required for synaptic vesicle 
acidification [25, 26], using the FLP-3::Venus and IDA-1::GFP reporters described above. 
unc-32 mutants had low neuropeptide levels and high IDA-1::GFP levels at synapses, 
molecular defects similar to those of vps-50 mutants (Fig. S5A–D). (unc-32 mutants are 
small, sickly, and severely impaired in locomotion (Fig. S5E). For this reason unc-32 
mutants cannot be assessed for locomotory responses to external cues for comparison with 
vps-50 mutants.) We then analyzed the acidification of synaptic and dense-core vesicles in 
intact worms by expressing synaptopHluorin (SpH) using the unc-17 promoter. SpH is a 
fusion of the synaptic-vesicle protein synaptobrevin with the pH-sensitive GFP reporter 
pHluorin, and the pHluorin moiety is localized to the vesicular lumen, where it can be used 
to assay vesicle pH [27, 28]. SpH has been used to study the effects of mutations in the V-
ATPase complex on C. elegans GABAergic neurons [25]. vps-50 mutants, like unc-32 
mutants, showed increased SpH fluorescence, indicating that vps-50 mutants are defective in 
vesicle acidification (Fig. 6B–C). unc-32 mutants share several aspects of the vps-50 mutant 
phenotype. However, whereas unc-32 mutants have low levels of synaptobrevin (SNB-1) at 
synapses, vps-50 mutants have normal levels (Fig. 6C). Since SpH is a SNB-1::pHluorin 
fusion, unc-32 likely has a greater effect than vps-50 on V-ATPase complex activity. The 
increased SpH fluorescence in vps-50 mutant animals is unlikely to be the result of SpH 
missorting in these mutants, as SpH colocalizes with the vesicular acetylcholine transporter 
UNC-17 in both wild-type and vps-50 mutant animals (Fig. S5F) and SpH localization to 
dorsal cord synapses in vps-50 mutants is dependent on UNC-104/KIF1A, as in the wild 
type (Fig. S5G). Impaired endocytosis at synapses could also lead to increased SpH 
fluorescence by causing an accumulation of SpH at the plasma membrane. To ask whether 
vps-50 mutants fail to recycle SpH, we compared them to mutants for unc-11, the AP180 
homolog; unc-11 mutants fail to recycle synaptic vesicle-associated proteins like SpH and 
show a diffusion of SpH (and SNB-1) all along the plasma membrane [29]. The diffusion of 
synaptic vesicleassociated proteins in unc-11 mutants is independent of UNC-104/KIF1A 
function, as unc-11; unc-104 double mutants similarly show diffusion of SNB-1 along the 
plasma membrane in neuronal processes [29]. By contrast, we observed no such diffusion of 
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SpH in unc-104; vps-50 double mutants (Fig. S5G). We conclude that vps-50 controls the 
acidification of vesicles rather than affect the levels of surface SpH.
To test if the role of VPS-50 in vesicle acidification is evolutionarily conserved, we used 
shRNAs to knock down mVps50 levels in mouse primary cultured cortical neurons 
transfected with a synaptophysin-pHluorin fusion (SypHy) [30]. We observed that neurons 
reduced in mVPS50 levels had higher SypHy fluorescence levels than wild-type neurons 
(Fig. 6D). Most SypHy signal, like the SpH signal observed in C. elegans, is from synaptic 
vesicles, which are more abundant than dense-core vesicles. Thus, disruption of mVps50 led 
to an acidification defect of synaptic vesicles in murine neurons. This observation further 
establishes the evolutionarily conserved functions of VPS-50 and mVPS50. Increasing the 
intravesicular pH to 7.4 using NH4Cl (see Experimental Procedures) increased the SypHy 
fluorescence of wild-type and mVps50 knockdown neurons to similar levels. Thus, the high 
SypHy fluorescence observed in neurons depleted for mVps50 resulted from a defect in 
vesicle acidification and not from a difference in SypHy expression, since neutralizing the 
pH of the vesicular lumen resulted in comparable SypHy fluorescence levels for wild-type 
and mVps50 knocked-down neurons.
Since the signals from the SpH and SypHy reporters are predominantly from synaptic 
vesicles, we developed a new reporter to assess the acidification of dense-core vesicles 
specifically. We fused both mCherry and pHluorin to the C-terminal end of a neuropeptide 
reporter encoding the first five neuropeptides of the flp-3 gene 
(FLP-31–5::mCherry::pHluorin); neuropeptides are found in dense-core vesicles but not in 
synaptic vesicles. mCherry, which is largely pH-insensitive, provides an internal control. We 
expressed this reporter in cholinergic neurons and used the ratio of the pHluorin/mCherry 
fluorescence intensities as a measure of pH. (A previous study showed that such a pHluorin/
mCherry ratio indicates pH [31]). The intramolecular ratiometric nature of our reporter is 
important, because we use this neuropeptide reporter in mutants that have altered 
neuropeptide levels; this reporter allows us to normalize for these different neuropeptide 
levels. That the FLP-31–5::mCherry::pHluorin reporter is indeed vesicle-associated is 
confirmed by the observation that its transport to the dorsal nerve cord is UNC-104/KIF1A-
dependent (data not shown); UNC-104/KIF1A transports dense-core and synaptic vesicles. 
Furthermore, the FLP-31–5::mCherry::pHluorin reporter can be observed in coelomocytes, 
indicating its release (see above) and establishing that it accurately reflects neuropeptide 
trafficking. Since FLP-3 is a soluble peptide, the FLP-31–5::mCherry::pHluorin reporter 
should be localized to the lumen of dense-core vesicles, unlike the SpH reporter (a fusion 
between pHluorin and the membrane protein synaptobrevin), which is localized to both 
synaptic vesicles and the plasma membrane. Thus, the FLP-31–5::mCherry::pHluorin 
reporter yields a more specific signal for intravesicular acidity than does SpH. Mutants for 
vps-50 and the V-ATPase subunit gene unc-32 showed impaired dense-core vesicle 
acidification as their pHluorin/mCherry fluorescence intensity ratios were higher than that of 
wild-type animals (Fig. 6E).
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mVPS50 functions in the assembly of the V-ATPase complex
Taken together, our results demonstrate that C. elegans vps-50 functions in the maturation 
and acidification of dense-core vesicles and through the acidification process affects 
neuropeptide signaling. Given that VPS-50 interacts with VHA-15, the H subunit 
responsible for the assembly of the soluble and membrane-bound moieties of the complex, 
we hypothesized that through its interaction with VHA-15, VPS-50 might function in the 
assembly of the V-ATPase complex onto synaptic and dense-core vesicles, thus regulating 
vesicle acidification. To test this hypothesis, we analyzed the presence of two of the soluble 
subunits of the V-ATPase complex, V1 subunits A and B, on synaptic vesicles in control 
mouse cultured primary neurons and in neurons knocked down for mVps50. The rationale 
for this experiment was that these soluble A and B subunits would be present on the 
membrane of synaptic vesicles only when the V-ATPase complex is fully assembled. We 
purified the synaptosomal fraction and analyzed the amounts of V-ATPase V1 A and B 
subunits by immunoblotting. We found that knockdown of mVps50 decreased the levels of 
synaptosomal V-ATPase subunits A and B as compared to control fractions (Fig. 6F). The 
total levels of these subunits were not affected in a whole-cell lysate, indicating that the 
decreased synaptosomal levels observed in the mVps50 knockdown were not caused by 
generally lower V-ATPase V1 A and B subunit levels (Fig. 6F). Taken together, our results 
suggest that C. elegans VPS-50 and its mammalian homologs are required for the proper 
assembly of the V-ATPase subunits into a functional holoenzyme, a process necessary for 
vesicle acidification. Alternatively, it is possible that VPS-50 acts in the sorting of the V-
ATPase subunits to their site of assembly, which could lead to the formation of abnormal 
vesicles that are impaired in acidification.
Discussion
We propose that VPS-50 regulates the behavioral state of C. elegans by controlling dense-
core vesicle maturation and acidification and thereby modulating neuropeptide signaling. 
VPS-50 and its mammalian homologs likely share an evolutionarily conserved function in 
V-ATPase complex assembly or sorting, leading to the generation of immature or otherwise 
abnormal dense-core vesicles impaired in vesicular acidification. The V-ATPase complex 
functions broadly to acidify cellular compartments, and the differential expression of subunit 
isoforms can confer cellular specificity to the localization and function of the complex [21]. 
It is possible that VPS-50 and its homologs regulate the V-ATPase complex specifically in 
neurons. VPS-50 might function in vesicle acidification as early as the trans-Golgi, from 
which dense-core vesicles are generated. Interestingly, recent studies have shown that fly 
and human VPS50 can associate with components of the Golgi-Associated Retrograde 
Protein (GARP) complex, which functions in retrograde transport from endosomes to the 
trans-Golgi, suggesting that vps-50 might act in protein sorting [32–35]. GARP consists of 
four proteins: VPS51, VPS52, VPS53 and VPS54. VPS50 replaces VPS54 in an alternative 
complex, the Endosome-Associated Recycling Protein (EARP) complex, which shares the 
VPS51, VPS52, and VPS53 subunits with GARP. Based in those interactions, the murine 
and human proteins have been names VPS50. (We note that VPS50 is referred to as 
Syndetin [34] or VPS54L [35] in two of these studies.) These reports further suggest that 
VPS50 localizes in part to recycling endosomes and that knockdown of VPS50 leads to 
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impaired recycling of proteins to the plasma membrane. These observations are consistent 
with our findings that vps-50 mutants show altered neuropeptide and dense-core vesicle 
protein levels at synapses and that mVps50-depleted neurons show impaired assembly or 
sorting of V-ATPase complex subunits. We suggest that the EARP complex could function in 
the maturation of dense-core vesicles.
unc-31 functions in dense-core vesicle release [12]. Mutations in vps-50 and unc-31 both 
lead to low levels of neuropeptide secretion as well as to similar behavioral phenotypes. 
Disruption of CADPS2, the mammalian homolog of unc-31, in both mouse and humans has 
been linked to autism spectrum disorders [36, 37]. In addition, a deletion spanning only 
hVPS50 (the human homolog of vps-50) and a second gene, CALCR (calcitonin receptor), 
has been reported in an autistic patient [38]. We suggest that VPS-50 plays a fundamental 
role in synaptic function and in the modulation of behavior and that an understanding of 
vps-50 and its mammalian homologs might shed light on mechanisms relevant to human 
behavior and possibly to neuropsychiatric disorders, including autism spectrum disorders.
Experimental Procedures
Behavioral analysis
For locomotion analyses, young adult worms were washed off a plate with S Basal medium 
and allowed to sediment in a 1.5 mL tube. Liquid was removed by aspiration, and worms in 
about 100 µL of S Basal were transferred to the center of an assay plate seeded with an E. 
coli OP50 lawn covering the entire surface. For tracking in the absence of bacteria, worms 
were washed an extra time in S Basal before transfer to an unseeded plate. After 30 minutes 
in the absence of bacteria, worms were washed off with S Basal and transferred to a new 
seeded plate. We used a worm tracker [39] to record 10 min videos. The average speed of 
the population between minutes 3 and 4 of the recording is reported. The developmental 
stages of laid eggs were scored as described [40]. For pharyngeal pumping rates, animals 
were recorded at 25 fps using a Nikon SMZ18 microscope with a DS-Ri2 camera and the 
videos were scored for pumping events during a 10 second window.
Microscopy and immunohistochemistry
For analysis of coelomocyte fluorescence, worms were immobilized in 30 mM NaN3 on 
NGM pads, and z-stacks of images were acquired using a Zeiss LSM510 confocal 
microscope. Maximal intensity projections of the coelomocytes were analyzed using 
ImageJ. Worms expressing other fluorescent reporters were immobilized with polystyrene 
beads on pads made of 10% agarose in M9 and imaged using a Zeiss Axioskop II 
microscope and a Hamamatsu ORCA-ER camera, with the exception of worms expressing 
the FLP-3::mCherry::pHluorin fusion, which were imaged using a Nikon Eclipse Ti 
microscope and a Princeton Instrument Pixis 1024 camera. Images were analyzed using 
ImageJ. Fluorescence intensities were quantified using a selected region of interest (ROI) 
from which we subtracted a background of equal size from a nearby region. The dorsal 
nerve cord was imaged near where the posterior gonad arm turns. For quantification of the 
FLP-3::mCherry::pHluorin fusion fluorescence intensities, the “Subtract background” option 
of ImageJ was used prior to selecting ROIs as above. For immunohistochemistry, worms 
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were washed off plates in PBS 1× and transferred to a 1.5 mL tube. Animals were washed 
three times and frozen in liquid nitrogen in about 150 µL of PBS 1×. Aliquots were thawed 
and pressed between two glass slides and placed on dry ice for 10 min. Glass slides were 
pulled apart and covered in ice-cold methanol in 50 mL tubes. Worms were washed off glass 
slides using a Pasteur pipette, and the glass slides were removed from the tube. Tubes were 
centrifuged 5 min at 3700 rpm. Worms were retrieved using a Pasteur pipette and transferred 
to a clean 1.5 mL tube. Methanol was removed. Worms were incubated in acetone for 5 min 
on ice. Worms were rehydrated three times in PBS 1× and incubated overnight at 4 °C with 
rabbit monoclonal anti-GFP antibody (1:100) (Invitrogen) and mouse monoclonal anti-
SNB-1 (1:100) antibody or mouse anti-UNC-17 (1:100) antibody (gift from J. Rand). 
Secondary antibodies were goat anti-rabbit and anti-mouse antibodies coupled with Alexa 
594 and Alexa 488 (1:2500), respectively (Invitrogen). Images were acquired using a Zeiss 
Axioskop II.
Primary hippocampal and cortical neuron cultures
All manipulations were performed in accord with the guidelines of the MIT Institutional 
Animal Care and Use Committee. Primary neuron cultures were prepared from embryonic 
day 15 (E15) mice. Hippocampus or cortex was dissected and treated with papain 
(Worthington) and DNaseI (Sigma) for 10 min at 37 °C and triturated with a fire-polished 
Pasteur pipette. Cells were plated at the density of 5×104 cells / cm2 on coverslips or plastic 
plates that were pre-coated with alpha-laminin and poly-D-lysine and cultured in Neurobasal 
medium supplemented with B-27.
Immunocytochemistry and immunohistochemistry of mouse neurons
For immunocytochemistry, mouse cultured neurons were fixed with 4% paraformaldehyde 
in PBS for 10 min, permeabilized and blocked with 5% goat serum and 0.3% Triton X-100 
in PBS for 1 hour. After incubation with primary antibodies overnight at 4 °C and with 
secondary antibodies for 1 hour at room temperature, coverslips were mounted with 
Fluoromount-G (Electron Microscopy Sciences). z-stack images were taken using a Nikon 
PCM 2000 or C2 confocal microscope with a 60× oil objective (N.A. 1.4) at 0.5 µm z-
intervals. For immunohistochemistry, VGAT-Venus mice were perfused with 4% 
paraformaldehyde in PBS, cryoprotected in 30% sucrose and sectioned at 60 µm on a 
freezing microtome. Sagittal sections were permeabilized and blocked in 5% goat serum and 
1% Triton X-100 in PBS. Sections were incubated with primary antibodies overnight at 4 °C 
and secondary antibodies for 2 hours at room temperature, and mounted with Fluoromount-
G. z-stack images were taken using a Nikon PCM 2000 confocal microscope with a 10× 
objective (N.A. 0.5) at 10 µm z-intervals. The figures presented are projections from these 
confocal z-stacks. Image analysis was performed by ImageJ software. Antibodies used were: 
mVPS50/CCDC132 (rabbit, Sigma), Chromogranin C (mouse, Abcam), neuropeptide Y 
(sheep, Millipore), GFP (rat, Nacalai), NeuN (mouse, Millipore), GM130 (mouse, BD 
Biosciences), Golgin-97 (mouse, Santa Cruz), TGN-43 (sheep, Serotec). Secondary 
antibodies were: goat anti-mouse, anti-rabbit, anti-rat or anti-sheep conjugated with Alexa 
488, Alexa 543 or Alexa 633 (Invitrogen).
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Transfection and confocal imaging of SypHy
Cultured cortical neurons were co-transfected with SypHy and shRNA or control plasmids 
using Lipofectamine 2000 (Invitrogen) at DIV (days in vitro) 5–7 and imaged using a Nikon 
PCM 2000 or C2 confocal microscope with a 60× water objective (N.A. 1.0) at DIV 10–14. 
Imaging was performed using a modified Tyrode's solution containing 150 mM NaCl, 4 mM 
KCl, 2 mM MgCl2, 2 mM CaCl2, 10 mM glucose, and 10 mM HEPES (pH 7.4). 50 µM 
AP-5 and 10 µM CNQX were added to prevent excitotoxicity. A modified Tylode solution 
substituting 50 mM NaCl with 50 mM NH4Cl was used to confirm the expression level of 
SypHy, as described previously [41].
Statistical tests
For colocalization experiments, Pearson’s correlation coefficients were obtained using the 
Coloc2 plugin in ImageJ. An ROI was drawn to include the cell bodies and dendrites. Bar 
graph comparisons were performed using Student’s t test, and multiple comparisons were 
corrected using the Holm-Bonferroni method. Additional experimental procedures are 
available in the Supplemental Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
VPS-50 regulates the behavioral state of C. elegans. A) The locomotory behavior of C. 
elegans is modulated by the presence of food and past feeding experience. Well-fed wild-
type animals move more slowly on a bacterial lawn (red bars) than in the absence of bacteria 
(blue bars), and food-deprived animals (green bars) slow even more than well-fed animals 
[1]. vps-50 mutants (n3925 and n4022) moved as if they were food-deprived even when 
well-fed, and this behavioral defect was rescued by a transgene expressing a GFP-tagged 
wild-type copy of vps-50 from its endogenous promoter. n = 6 plates for the wild type; n = 3 
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plates for all other genotypes. Mean ± SD. B) vps-50 mutants show normal pumping rates, 
indicating that they do not have a feeding defect. C) vps-50 mutants develop at a rate similar 
to that of wild-type animals. We followed synchronized animals after recovery from L1 
arrest. All wild-type and vps-50 mutant worms observed had a developed vulva after 44 
hours; 12/12 wild-type animals were gravid after 49 hours, while 11/12 vps-50 mutants were 
gravid after 49 hours. D) Analyses of the in utero retention time of eggs, assayed by the 
distribution of the developmental stages of newly laid eggs. vps-50 mutants retained eggs in 
utero for an abnormally long period of time, as seen by a shift to later stages of their newly 
laid eggs. The egg-laying defect of vps-50 mutants was rescued by transgenes expressing 
vps-50 under its endogenous promoter or a pan-neuronal promoter but not under a body-wall 
muscle promoter. See also Figure S1.
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Figure 2. 
VPS-50 functions in neurons. A) Fluorescence and Nomarski micrographs of regions of C. 
elegans transgenic animals expressing VPS-50::GFP (nIs388) using the vps-50 promoter. 
vps-50 was expressed in most if not all neurons. Occasional expression was observed in 
some pharyngeal muscles. VNC: ventral nerve cord. #To enhance visualization, we used 
unc-104(e1265) mutant animals to increase the fluorescence level in cell bodies. Scale bars: 
10 µm. B) vps-50 functions in neurons to regulate locomotion. vps-50 was expressed pan-
neuronally (Prab-3) and in body-wall muscles (Pmyo-3) to identify its site of action. Pan-
neuronal expression of vps-50, or of its murine homolog mVps50, rescued the locomotion 
defect of vps-50(n4022) animals. n = 3 plates for all genotypes. C) vps-50 functions in 
cholinergic neurons to regulate locomotion on food. vps-50 was expressed in cholinergic 
neurons (Punc-17), in GABAergic neurons (Punc-47) and in a subset of sensory neurons 
(Ptax-2) to identify its site of action. n = 5 plates for the wild type and vps-50(n4022); n = 3 
plates for all other genotypes. D) The localization of VPS-50::GFP to synapse-rich areas of 
the nerve ring depends on UNC-104/KIF1A, a molecular motor that transports synaptic 
vesicles and their associated proteins to synapses. Immunohistochemistry against GFP and 
synaptobrevin (SNB-1) and DAPI staining are shown. The dotted line indicates the synapse-
rich nerve ring, and clusters of neuronal cell bodies are marked. For panels B and C, 
significance is defined by comparison to the equivalent state for vps-50(n4022) mutants.
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Figure 3. 
mVPS50 is widely expressed in the mammalian brain neurons. Anti-VPS50 antibodies 
specifically recognize mVPS50 (see Fig. S2A–B for validation of the anti-mVPS50 
antibody). A) mVPS50 is enriched in brain tissue. Protein extracts from dissected adult 
mouse tissues were analyzed for mVPS50 expression by immunoblotting. B) mVPS50 is 
expressed in most brain regions, with strong expression in cortex and hippocampus. C) 
mVPS50 is expressed in the mouse cortex throughout postnatal (P) development. Protein 
extracts from dissected mouse cortex were analyzed for mVPS50 expression at different 
developmental stages. D) mVPS50 is expressed broadly in the mouse hippocampal neurons. 
Transgenic mice that express VGAT-Venus in inhibitory neurons were used for 
immunohistochemical studies of sagittal hippocampal slices [9]. The dentate gyrus and CA3 
are shown. The mVPS50 immunostaining overlaps with neuron specific marker NeuN 
including both Venus-positive inhibitory neurons and Venus-negative excitatory neurons. 
Scale bar: 100 µm. See also Figure S2.
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Figure 4. 
mVPS50 associates with synaptic and dense-core vesicles. A) mVPS50 does not colocalize 
with the cis-Golgi apparatus (GM130) in mouse primary cultured cortical neurons. B) 
mVPS50 partially colocalizes with the trans-Golgi apparatus (Golgin-97) in mouse primary 
cultured cortical neurons. C) mVPS50 partially colocalizes with Chromogranin C-containing 
dense-core vesicles (ChrC) in mouse primary cultured cortical neurons. D) mVPS50 
partially colocalizes with neuropeptide Y-containing dense-core vesicles (NPY) in mouse 
primary cultured cortical neurons. Endogenous mVPS50, GM130, Golgin-97, ChrC and 
NPY were detected by immunofluorescence. Scale bar for A–B: 10 µm. Scale bar for C-D: 5 
µm. E) mVPS50 significantly cofractionates with the synaptic vesicle protein synaptophysin 
and the neuropeptide Chromogranin C. Extracts from adult mouse cortex were fractionated, 
and fractions were probed by immunoblotting for mVPS50, the NMDA glutamate receptor 
subunit GluN1, the postsynaptic density protein PSD-95, the neuropeptide Chromogranin C, 
the synaptic vesicle membrane protein synaptophysin, the cytoplasmic V-ATPase A and H 
subunit (the mammalian homolog of C. elegans VHA-15) and the vesicle coat protein 
clathrin heavy chain. F) mVPS50 is a soluble protein. The synaptic vesicle and cytosol 
(LS1) fraction from adult mouse cortex was further fractionated using sucrose gradient 
centrifugation, and fractions were probed by immunoblotting. See also Figure S3.
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Figure 5. 
vps-50 disruption reduces neuropeptide levels and impairs neuropeptide processing. A) 
Modulation of locomotion in response to the presence of food and past feeding experience. 
Like vps-50 mutants, unc-31 (CADPS2) and rab-2 (Rab2) mutants, which are defective in 
dense-core vesicle release and maturation, respectively, behave as if they had been food-
deprived even when well-fed; egl-3 (PC2) mutants are more similar to wild-type animals. n 
= 4 plates for wild type; n = 3 plates for all other genotypes. B). Mutant animals defective in 
the synthesis of biogenic amines (cat-2: dopamine, tph-1: serotonin, tdc-1: tyramine and 
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octopamine) behave differently when well-fed or food-deprived, unlike vps-50 mutants. n = 
10 plates for wild type; n = 3 plates for all other genotypes. C) vps-50 mutants, like rab-2 
mutants, show reduced FLP-3::Venus neuropeptide levels in the C. elegans dorsal nerve 
cord. unc-31 and egl-3 mutants show elevated neuropeptide levels at synapses. D) vps-50 
mutants do not significantly accumulate FLP-3::Venus neuropeptides in neuronal cell 
bodies. E) vps-50 mutants have reduced levels of FLP-3::Venus neuropeptides in 
coelomocytes. F) vps-50 mutants do not have a dense-core vesicle maturation defect 
identical to that of rab-2 mutants based on the dense-core vesicle marker IDA-1::GFP in the 
C. elegans dorsal nerve cord. G) vps-50 mutants, like rab-2 mutants, abnormally accumulate 
IDA-1::GFP in ventral nerve cord cell bodies. H) vps-50 mutants have reduced levels of the 
neuropeptide FLP-3 as well as reduced FLP-3 processing. Immunoblots of C. elegans 
protein extracts showing the levels of processed and unprocessed neuropeptide 
FLP-3::Venus and the constant levels of the synaptobrevin reporter mCherry::SNB-1. The 
transgene ceIs61 expressed both FLP-3::Venus and mCherry:SNB-1 from the unc-129 
promoter. Mutants for the proprotein convertase 2 homolog EGL-3 had no detectable fully 
processed FLP-3 neuropeptides. I) vps-50 mutants show reduced NLP-21::Venus 
neuropeptide levels in the C. elegans dorsal nerve cord. Scale bars: 5 µm. Bar graphs A and 
B, means ± SDs. Bar graphs C–G & I, n values (number of animals) are indicated on bars, 
representative fluorescence micrographs and quantification are shown, means ± SEMs. See 
also Figure S4.
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Figure 6. 
Disruption of vps-50 in C. elegans or of its murine homolog mVps50 in mouse cultured 
neurons similarly impair synaptic vesicle acidification. A) VPS-50 can associate with the V-
ATPase subunit VHA-15 in the yeast two-hybrid assay. Growth occurred on media lacking 
histidine (dark triangle). B) vps-50 mutants have a synaptic vesicle acidification defect. 
Representative micrographs and quantification of synaptopHluorin (SpH) fluorescence 
levels. SpH fluorescence is quenched by acidic pH; thus, increased fluorescence levels 
correspond to increased pH. Mutants defective in the V-ATPase complex subunit gene 
unc-32 were used as an acidification-defective control [25]. C) vps-50 mutants did not have 
elevated levels of synaptobrevin SNB-1 at synapses, indicating that the higher SpH (a 
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SNB-1::pHluorin fusion) fluorescence levels observed in vps-50 and unc-32 mutants were 
not caused by elevated levels of SpH at synapses. Representative fluorescence micrographs 
and quantification of mCherry::SNB-1 levels at synapses. D) Knockdown of mVps50 in 
mouse primary cultured cortical neurons led to a synaptic vesicle acidification defect. 
Quantification of SypHy (synaptophysin-pHluorin fusion) fluorescence levels with or 
without knockdown of mVps50. Higher fluorescence levels correspond to higher pH. SypHy 
expression levels in wild-type and mVps50 knocked-down neurons are similar, as addition 
of NH4Cl to increase the intravesicular pH to 7.4 led to similar SypHy fluorescence levels in 
both. E) vps-50 mutants have a dense-core vesicle acidification defect. pHluorin and 
mCherry fluorescence intensities were quantified from FLP-31–5::mCherry::pHluorin 
reporter. An increased pHluorin/mCherry fluorescence ratio indicates increased pH. Mutants 
defective in the V-ATPase complex subunit gene unc-32 were used as an acidification-
defective control. F) Knockdown of mVps50 in mouse primary cultured cortical neurons 
reduces the amount of V-ATPase (V1) subunits A and B in the synaptosomal fraction. Levels 
of V-ATPase soluble subunits A and B were quantified in total protein extracts and in 
synaptosomal fractions in wild-type and mVps50 knockdown primary cultured neurons. n = 
6. Scale bars: 5 µm. Bar graphs, n values (number of animals or neurons) are indicated on 
bars, means ± SEMs. See also Figure S5.
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